HIV-infected individuals experience up to 4-fold higher annual rates of fragility fractures than the general population. As HIV-infected individuals live longer through effective antiretroviral therapy (ART), fracture rates are expected to further increase in the future. While several studies have emphasized an increased fracture incidence in HIV-infected patients, this increased fracture incidence is not explained by differences in bone mineral density (BMD) between HIV-infected individuals and healthy controls. An emerging explanation for this paradox is that HIV infection and treatment are associated with bone quality changes ? including changes in bone geometry and microstructure ? that do not impact BMD but do increase fracture risk. To date, only a few studies have investigated bone quality and only at the distal extremities. However, the proximal femur is an important site for fragility fracture. Hence, a critical gap in knowledge is whether bone quality at central skeletal sites, including the spine and hip, is similarly affected by HIV infection and therapy. Thus, a critical barrier to progress in the field is a lack of understanding of bone quality changes in HIV infected subjects. A potential mechanism influencing low bone quality in HIV could be an imbalance in bone and fat cell differentiation. Thus, bone marrow fat (BMF) could potentially be another important biomarker for bone health. A better understanding of these relationships could translate into new approaches for fracture risk assessment, drug development, and therapy monitoring in HIV-infected patients. We have identified three working hypotheses: (1) Significant micro-structural deterioration and reduction in biomechanical competence will be detected in HIV-infected patients at both peripheral and central sites and will reveal larger differences between HIV-infected and control groups than BMD data from DXA alone; (2) Increased BMF will be detected in HIV-infected patients compared to healthy controls and will be associated with increased visceral adiposity and decreased HIV-associated subcutaneous adiposity; and (3) Increased BMF will partially explain the association of HIV with poor bone quality. These hypotheses will be tested by pursuing the following Specific Aims: (1) Quantify differences in bone density, structure, and mechanical properties between HIV-infected patients and uninfected controls; (2) Determine differences in BMF between HIV-infected patients and uninfected controls; and (3) Determine the relationship between BMF and bone quality in HIV-infected patients. The approach is innovative because it combines novel in-vivo MRI and HR-pQCT imaging techniques to determine relationships between bone features and BMF with voxel based morphormetry. The proposed research is significant because the associations between bone quality and BMF have not yet been assessed in HIV-infected subjects. These relationships may reveal pathobiological mechanisms at play in HIV, and identify potential therapeutic targets for improving skeletal health in the HIV-infected population.

Public Health Relevance

The proposed research is relevant to public health because of the high prevalence of fragility fractures in an aging population of HIV-infected patients and the significant burden of high mortality rates and cost to society. There is evidence that bone micro-structure and bone marrow fat both play important roles in skeletal health of HIV-infected patients. The results from this study will allow us to better understand the association of marrow fat and bone quality in HIV. Thus, our findings will help to better understand biological mechanisms impacting elevated fracture risk in HIV. This will have an important positive impact on current treatment strategies and further drug development. Thus, the proposed research is relevant to the part of NIH's mission that pertains to developing fundamental knowledge that will help to reduce the burdens of human disability.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Chiou, Chen-Chia Christine C
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California San Francisco
Schools of Medicine
San Francisco
United States
Zip Code
Kazakia, Galateia J; Carballido-Gamio, Julio; Lai, Andrew et al. (2018) Trabecular bone microstructure is impaired in the proximal femur of human immunodeficiency virus-infected men with normal bone mineral density. Quant Imaging Med Surg 8:5-13
Karampinos, Dimitrios C; Ruschke, Stefan; Dieckmeyer, Michael et al. (2018) Quantitative MRI and spectroscopy of bone marrow. J Magn Reson Imaging 47:332-353